Type-specific human papillomavirus dna in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia

British Journal of Cancer

Volumn 69, Issue 1, 1994, Pages 167-171

  Cuzick, J ^a   Terry, G ^b   Ho, L ^b   Hollingworth, T ^c   Anderson, M ^d  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; COLPOSCOPY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

BASE SEQUENCE; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX DISEASES; CERVIX NEOPLASMS; COLPOSCOPY; DNA, VIRAL; FEMALE; HUMAN; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRUS, HUMAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VAGINAL SMEARS;

EID: 0028144366     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1994.28     Document Type: Article

References (32)

1. BARTON, S.E., JENKINS, D., HOLLINGWORTH, A., CUZICK, J. & SINGER, A. (1989). An explanation for the problem of false-negative cervical smears. Br. J. Obstet. Gynaecol., 96, 482–485.
2. BANDA-GAMBOA, H., RICKETTS, I., CAIRNS, A., HUSSEIN, K., TUCKER, J.H. & HUSAIN, N. (1992). Automation in cervical cytology: an overview. Anal. Cell. Pathol., 4, 25–48.
3. BAUER, H.M., TING, Y., GREER, C.E., CHAMBERS, J.C., TASHIRO, J., CHIMERA, J., REINGOLD, A. & MANOS, M.M. (1991). Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA, 265, 472–477.
4. BAVIN, P.J., GILES, J.A., DEERY, A., CROW, J., GRIFFITHS, P.D., EMERY, V.C. & WALKER, P.G. (1993). Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br. J. Cancer, 67, 602–605.
5. COLE, S.T. & DANOS, O. (1987). Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. J. Mol. Biol., 193, 599–608.
6. COLE, S.T. & STREECK, R.E. (1986). Genome organisation and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J. Virol., 58, 991–995.
7. CUZICK, J., TERRY, G., HO, L., HOLLINGWORTH, T. & ANDERSON, M. (1992a). Human papillomavirus type 16 DNA in cervical smears as predictor of high-grade cervical intraepithelial neoplasia. Lancet, 339, 959–960.
8. CUZICK, J., TERRY, G., HO, L., HOLLINGWORTH, T. & ANDERSON, M. (1992b). HPV in cervical smears. Lancet, 340, 112–113.
9. DARTMANN, K., SCHWARZ, E., GISSMANN, L. & ZUR HAUSEN, H. (1986). The nucleotide sequence and genome organization of human papilloma virus type 11. Virology, 151, 124–130.
10. GOLDSBOROUGH, M.D., DISELVESTRE, D., TEMPLE, G.F. & LORINCZ, A.T. (1989). Nucleotide sequence of human papillomavirus type 31: a cervical neoplasia associated virus. Virology, 171, 306–311.
11. GRAVITT, P.E. & MANOS, M.M. (1992). Polymerase chain reaction-based methods for the detection of human papillomavirus DNA. In The Epidemiology of Human Papillomavirus and Cervical Cancer, Munoz, N., Bosch, F.X., Shah, K.V. & Meheus, A. (eds). IARC Scientific Publication No. 119, pp. 121-133. IARC: Lyon.
12. HAKAMA, M. (1982). Trends in incidence of cervical cancer in the Nordic countries. In Trends in Cancer Incidence: Causes and Practical Implications, Magnus, K. (ed.), pp. 279-292. Hemisphere: New York.
13. HAKAMA, M., MAGNUS, K., PETTERSSON, F., STORM, H. & TULINIUS, H. (1991). Effect of organized screening on the risk of cervical cancer in the Nordic countries. In Cancer Screening, Miller, A.B., Chamberlain, J., Day, N.E., Hakama, M. & Prorok, P.C. (eds). pp. 153-162. Cambridge University Press: Cambridge.
14. IARC WORKING GROUP (1986). Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br. Med. J., 293, 659–664.
15. KOUTSKY, L.A., HOLMES, K.K., CRITCHLOW, C.W., STEVENS, C.E., PAAVONEN, J., BECKMANN, A.M., DEROUEN, T.A., GALLOWAY, A., VERNON, D. & KIVIAT, N.B. (1992). A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. New Engl. J. Med., 327, 1272–1278.
16. LAARA, E., DAY, N.E. & HAKAMA, M. (1987). Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet, i, 1247–1249.
17. LORINCZ, A T., QUINN, A.P., LANCASTER, W.D. & TEMPLE, G.F. (1991). A new type of papillomavirus associated with cancer of the uterine cervix. Virology, 159, 187–190.
18. LORINCZ, A T., REID, R., JENSON, A.B., GREENBERG, M.D., LANCASTER, W. & KURMAN, R.J. (1992). Human papillomavirus infection of the cervix: relative risk associations of fifteen common anogenital types. Obstet. Gynaecol., 99, 328–337.
19. MEANWELL, C.A., COX, M.F., BLACKLEDGE, G. & MAITLAND, N.J. (1987). HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia. Lancet, i, 703–707.
20. MITCHELL, H., MEDLEY, G. & GILES, G. (1990). Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s. Br. Med. J., 300, 1622–1626.
21. MUNOZ, N. & BOSCH, F.X. (1992). HPV and cervical neoplasia: review of case-control and cohort studies. In The Epidemiology of Human Papillomavirus and Cervical Cancer. Munoz, N., Bosch, F.X., Shah, K.V. & Meheus, A. (eds), IARC Scientific Publication No. 119, pp. 251-261. IARC: Lyon.
22. MUNOZ, N., BOSCH, F.X., DE SANJOSE, S., TAFUR, L., IZARZUGAZA, I., GILI, M., VILADIU, P., NAVARRO, C., MARTOS, C., ASCUNCE, N., GONZALEZ, L.C., KALDOR, J.M., GUERRERO, E., LORINCZ, A., SANTAMARIA, M., ALONSO DE RUIZ, P., ARISTIZABAL, N. & SHAH, K. (1992). The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer, 52, 743–749.
23. SCHIFFMAN, M.H., BAUER, H.M., LORINCZ, AT., MANOS, M.M., BYRNE, J.C., GLASS, A.G., CADELL, D M. & HOWLEY, P.M. (1991). Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J. Clin. Microbiol., 29, 573–577.
24. SCHWARZ, E., DUERST, M., DEMANKOWSKI, C., LATTERMANN, O., ZECH, R., WOLFSPERGER, E., SAHAI, S. & ZUR HAUSEN, H. (1983). DNA sequence and genome organization of genital human papillomavirus type 6b. EM BO J., 2, 2341–2348.
25. SEEDORF, K., KRAMMER, G., DURST, M., SUHAI, S. & ROWEKAMP, W.G. (1985). Human papillomavirus type 16 sequence. Virology, 145, 181–185.
26. STAFL, A. (1981). Cervicography: a new method for cervical cancer detection. Am. J. Obstet. Gynecol., 139, 815–825.
27. STOLER, M., GREER, C., SHICK, E., KURMAN, R., BONFIGLIO, T., KADISH, A., WHEELER, C. & MANOS, M. (1992). The association and type distribution of HPVs in adenocarcinoma of the uterine cervix (abstract). Lab. Invest., 66, 69A.
28. SZAREWSKI, A., CUZICK, J., EDWARDS, R., BUTLER, B. & SINGER, A., (1991). The use of cervicography in a primary screening service. Br. J. Obstet. Gynaecol, 98, 313-317 (correspondence, pp. 740-743).
29. TAWA, K., FORSYTHE, A., KAREN COVE, J., SALTZ, A., PETERS, H.W. & WATRING, W.G. (1988). A comparison of the papanicolaou smear and the cervigram: sensitivity, specificity, and cost analysis. Obstet. Gynaecol., 71, 229–235.
30. TERRY, G., HO, L., JENKINS, D., HILLS, M., SINGER, A., MANSELL, B. & BEVERLEY, E. (1993). Definition of human papillomavirus type 16 DNA levels in low and high grade cervical lesions by a simple polymerase chain reaction technique. Arch. Virol., 128, 123–133.
31. VAN DEN BRULE, A.J.C., WALBOOMERS, J.M.M., DU MAINE, M., KENEMANS, P. & MEIJER, C.J.L.M. (1991). Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int. J. Cancer, 48, 404–408.
32. YOUNG, L.S., BEVAN, I S., JOHNSON, M.A., BLOMFIELD, P.I., BROMIDGE, T., MAITLAND, N.J. & WOODMAN, C.B.J. (1989). The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. Br. Med. J., 298, 14–18.